Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Davidson

Showing results (311-320 of 358) with videos related to

Pageof 36
Sort By:
Current Biology : CB|April 9, 2013
NMII forms a contractile transcellular sarcomeric network to regulate apical cell junctions and tissue geometrySeham Ebrahim, Tomoki Fujita, Bryan A Millis, et al.
Schizophrenia Research|March 13, 2017
Consistency checks to improve measurement with the Positive and Negative Syndrome Scale (PANSS)Jonathan Rabinowitz, Nina R Schooler, Ariana Anderson, et al.
The New England Journal of Medicine|November 19, 2010
Safety of anacetrapib in patients with or at high risk for coronary heart diseaseChristopher P Cannon, Sukrut Shah, Hayes M Dansky, et al.
The Journal of Clinical Psychiatry|May 21, 2004
Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophreniaDaniel E Casey, Dan W Haupt, John W Newcomer, et al.
Schizophrenia Bulletin Open|August 15, 2024
Remote Assessment of Negative Symptoms of SchizophreniaDavid G Daniel, Alex S Cohen, Dawn Velligan, et al.
Cell Reports|October 13, 2016
Breast Cancer-Derived Lung Metastases Show Increased Pyruvate Carboxylase-Dependent AnaplerosisStefan Christen, Doriane Lorendeau, Roberta Schmieder, et al.
Schizophrenia Research|October 14, 2009
Correlates of cognitive impairment in first episode schizophrenia: the EUFEST studySilvana Galderisi, Michael Davidson, René S Kahn, et al.
The Journal of Clinical Psychiatry|July 17, 2012
A multicenter, add-on randomized controlled trial of low-dose d-serine for negative and cognitive symptoms of schizophreniaMark Weiser, Uriel Heresco-Levy, Michael Davidson, et al.
Schizophrenia Bulletin|August 30, 2008
What is causing the reduced drug-placebo difference in recent schizophrenia clinical trials and what can be done about it?Aaron S Kemp, Nina R Schooler, Amir H Kalali, et al.
Genetic Epidemiology|June 27, 2013
Statistical genetic analysis of serological measures of common, chronic infections in Alaska Native participants in the GOCADAN studyRohina Rubicz, Jianhui Zhu, Sandra Laston, et al.
Pageof 36

Showing results (311-320 of 358) with videos related to

Sort By:
Pageof 36
Current Biology : CB|April 9, 2013
NMII forms a contractile transcellular sarcomeric network to regulate apical cell junctions and tissue geometrySeham Ebrahim, Tomoki Fujita, Bryan A Millis, et al.
Schizophrenia Research|March 13, 2017
Consistency checks to improve measurement with the Positive and Negative Syndrome Scale (PANSS)Jonathan Rabinowitz, Nina R Schooler, Ariana Anderson, et al.
The New England Journal of Medicine|November 19, 2010
Safety of anacetrapib in patients with or at high risk for coronary heart diseaseChristopher P Cannon, Sukrut Shah, Hayes M Dansky, et al.
The Journal of Clinical Psychiatry|May 21, 2004
Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophreniaDaniel E Casey, Dan W Haupt, John W Newcomer, et al.
Schizophrenia Bulletin Open|August 15, 2024
Remote Assessment of Negative Symptoms of SchizophreniaDavid G Daniel, Alex S Cohen, Dawn Velligan, et al.
Cell Reports|October 13, 2016
Breast Cancer-Derived Lung Metastases Show Increased Pyruvate Carboxylase-Dependent AnaplerosisStefan Christen, Doriane Lorendeau, Roberta Schmieder, et al.
Schizophrenia Research|October 14, 2009
Correlates of cognitive impairment in first episode schizophrenia: the EUFEST studySilvana Galderisi, Michael Davidson, René S Kahn, et al.
The Journal of Clinical Psychiatry|July 17, 2012
A multicenter, add-on randomized controlled trial of low-dose d-serine for negative and cognitive symptoms of schizophreniaMark Weiser, Uriel Heresco-Levy, Michael Davidson, et al.
Schizophrenia Bulletin|August 30, 2008
What is causing the reduced drug-placebo difference in recent schizophrenia clinical trials and what can be done about it?Aaron S Kemp, Nina R Schooler, Amir H Kalali, et al.
Genetic Epidemiology|June 27, 2013
Statistical genetic analysis of serological measures of common, chronic infections in Alaska Native participants in the GOCADAN studyRohina Rubicz, Jianhui Zhu, Sandra Laston, et al.
Pageof 36